{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:41:30Z","timestamp":1784011290484,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2019.07.053","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T16:35:15Z","timestamp":1564418115000},"page":"5297-5306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Development and pre-clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Neisseria meningitidis serogroup C"],"prefix":"10.1016","volume":"37","author":[{"given":"Juned","family":"Dalal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore","family":"Harale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarmad","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Chhikara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2019.07.053_b0005","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.07.053_b0010","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/315284","article-title":"Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine","volume":"181","author":"Richmond","year":"2000","journal-title":"J Infect Dis"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2019.07.053_b0015","first-page":"1232","article-title":"A randomized, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants","volume":"19","author":"English","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.07.053_b0020","first-page":"83","article-title":"Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A\/C polysaccharide vaccination in Saudi Arabia","volume":"11","author":"Jokhdar","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2019.07.053_b0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/iai.40.1.245-256.1983","article-title":"Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates","volume":"40","author":"Chu","year":"1983","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2019.07.053_b0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.13.2.302","article-title":"Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates","volume":"13","author":"Peltola","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"9251","key":"10.1016\/j.vaccine.2019.07.053_b0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England","volume":"357","author":"Ramsay","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.07.053_b0040","unstructured":"WHO. Situation update on meningitis C epidemic risk, 21 December 2017. http:\/\/www.who.int\/emergencies\/diseases\/meningitis\/meningitis-c-epidemic-risk\/en\/"},{"issue":"1","key":"10.1016\/j.vaccine.2019.07.053_b0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4049\/jimmunol.84.1.82","article-title":"The upper limit for the size of the human antidextran combining site","volume":"84","author":"Kabat","year":"1960","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2019.07.053_b0050","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1128\/IAI.00472-08","article-title":"Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14","volume":"76","author":"Safari","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.07.053_b0055","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1039\/C2CS35382B","article-title":"Designing a new antifungal glycoconjugate vaccine","volume":"42","author":"Johnson","year":"2013","journal-title":"Chem Soc Rev"},{"issue":"5683","key":"10.1016\/j.vaccine.2019.07.053_b0060","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1126\/science.1095209","article-title":"A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b","volume":"305","author":"Verez-Bencomo","year":"2004","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.vaccine.2019.07.053_b0065","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1128\/IAI.72.12.7115-7123.2004","article-title":"Antigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b","volume":"72","author":"Fernandez-Santana","year":"2004","journal-title":"Infect Immun"},{"issue":"35","key":"10.1016\/j.vaccine.2019.07.053_b0070","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1002\/anie.201302540","article-title":"Synthesis of Neisseria meningitidis serogroup W135 capsular oligosaccharides for immunogenicity comparison and vaccine development","volume":"52","author":"Wang","year":"2013","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.vaccine.2019.07.053_b0075","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3762\/bjoc.10.247","article-title":"Synthesis and immunological evaluation of protein conjugates of Neisseria meningitidis X capsular polysaccharide fragments","volume":"10","author":"Morelli","year":"2014","journal-title":"Belistein J Org Chem"},{"issue":"10","key":"10.1016\/j.vaccine.2019.07.053_b0080","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/acsinfecdis.5b00071","article-title":"A synthetic disaccharide analogue from Neisseria meningitidis A capsular polysaccharide stimulates immune cell responses and induces immunoglobulin G (IgG) production in mice when protein-conjugated","volume":"1","author":"Fallarini","year":"2015","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.053_b0085","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1021\/jo100824s","article-title":"5-N,4-O-carbonyl-7,8,9-tri-O-chloroacetyl-protected sialyl donor for the stereoselective synthesis of \u03b1-(2\u21929)-tetrasialic acid","volume":"75","author":"Lin","year":"2010","journal-title":"J Org Chem"},{"issue":"40","key":"10.1016\/j.vaccine.2019.07.053_b0090","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1002\/anie.201101794","article-title":"Efficient and stereoselective synthesis of \u03b1 (2\u21929) oligosialic acids: from monomers to dodecamers","volume":"50","author":"Chu","year":"2011","journal-title":"Angew Chem Int Ed Engl"},{"issue":"3","key":"10.1016\/j.vaccine.2019.07.053_b0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0006-3002(57)90254-8","article-title":"Quantitative estimation of sialic acids: a colorimetric resorcinol-hydrochloric acid method","volume":"24","author":"Svennerholm","year":"1957","journal-title":"Biochim Biohys Acta"},{"issue":"2","key":"10.1016\/j.vaccine.2019.07.053_b0100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0003-9861(58)90014-6","article-title":"A colorimetric method for determining low concentrations of mercaptans","volume":"74","author":"Ellman","year":"1958","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.vaccine.2019.07.053_b0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2019.07.053_b0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/biol.1997.0121","article-title":"A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Haemphilus influenzae type b in PRP-tetanus toxoid conjugate vaccine","volume":"26","author":"Guo","year":"1998","journal-title":"Biologicals"},{"issue":"6","key":"10.1016\/j.vaccine.2019.07.053_b0115","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/jcm.32.6.1475-1482.1994","article-title":"Multicenter comparison of Neisseria meningitidis serogroup C anticapsular polysaccharide antibody levels measured by a standardized enzyme linked immunosorbent assay","volume":"32","author":"Gheesling","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.07.053_b0120","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/cdli.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.07.053_b0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2019.07.053_b0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1517\/14712598.2015.993375","article-title":"Glycoconjugate vaccines: an update","volume":"15","author":"Vella","year":"2015","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2019.07.053_b0135","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.vaccine.2008.11.065","article-title":"Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa","volume":"27","author":"Lee","year":"2009","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2019.07.053_b0140","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.vaccine.2015.04.031","article-title":"Development and characterization of Haemophilus influenzae type b conjugate vaccine prepared using different polysaccharide chain lengths","volume":"33","author":"Rana","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.053_b0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chembiol.2014.01.002","article-title":"Chemical biology approaches to designing defined carbohydrate vaccines","volume":"21","author":"Anish","year":"2014","journal-title":"Chem Biol"},{"key":"10.1016\/j.vaccine.2019.07.053_b0150","first-page":"151","article-title":"Structure activity studies on group C meningococcal polysaccharide protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope","volume":"103","author":"Michon","year":"2000","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2019.07.053_b0155","first-page":"41332","article-title":"Synthesis of tetrasaccharide and glycoconjugate corresponding to the capsular polysaccharide of Neisseria meningitidis serogroup X and its immunochemical studies","volume":"52","author":"Harale","year":"2015","journal-title":"RCS Adv"},{"key":"10.1016\/j.vaccine.2019.07.053_b0160","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1039\/C7QO00468K","article-title":"Synthesis and immunochemical evaluation of a novel Neisseria meningitidis serogroup A tetrasaccharide and its conjugate","volume":"4","author":"Harale","year":"2017","journal-title":"Org Chem Front"},{"issue":"51","key":"10.1016\/j.vaccine.2019.07.053_b0165","doi-asserted-by":"crossref","first-page":"14518","DOI":"10.1002\/chem.201102615","article-title":"A highly \u03b1-Stereoselective synthesis of oligosaccharide fragments of the Vi antigen from Salmonella typhi and their antigenic activities","volume":"17","author":"Yang","year":"2011","journal-title":"Chem-Eur J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1930951X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1930951X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:59Z","timestamp":1759401239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1930951X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":33,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X1930951X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and pre-clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Neisseria meningitidis serogroup C","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}